Lopinavir/ritonavir combined with raltegravir or tenofovir/emtricitabine in antiretroviral-naive subjects: 96-week results of the PROGRESS study. Reynes J et al, AIDS Res Hum Retroviruses. 2013 Feb;29(2):256-65 Posted on March 25th, 2013 - Dr Anton Pozniak Dynamics of cellular HIV-1 DNA levels over 144 weeks of darunavir/ritonavir monotherapy versus triple therapy in the MONET trial. Geretti AM et al, HIV Clin Trials. 2013 Jan-Feb;14(1):45-50 Posted on March 11th, 2013 - Dr Anton Pozniak Back to Home page
Back to Home page